The Commission has authorised the Spikevax XBB.1.5-adapted COVID-19 vaccine, developed by Moderna. This is another important step in the fight against the disease. It is the third adaptation of this vaccine to respond to new COVID-19 variants. The European Medicines Agency (EMA) carried out a stringent evaluation of the vaccine under the accelerated assessment mechanism. Following this […]
Read More
Parliament endorsed new measures to better protect citizens who donate blood, tissues or cells
MEPs adopted the report on new rules governing the use of so-called substances of human origin (SoHO) in the EU, with 483 votes in favour, 52 against and 89 abstentions. The measures apply to substances – such as blood and its components (red/white cells, plasma), tissues and cells – used for transfusions, therapies, transplantations or […]
Read More
What is the European Union doing to reduce air pollution?
Poor air quality can cause respiratory and cardiovascular diseases, diabetes and cancer. But its devastating effects also extend to biodiversity, as it poisons crops and forests, causing significant economic losses. As part of the zero pollution ambition set out in the EU’s European Green Deal, the European Parliament has proposed setting stricter air quality standards […]
Read More
Commission authorises adapted COVID-19 vaccine for Member States’ autumn vaccination campaigns
The Commission has authorised the Comirnaty XBB.1.5-adapted COVID-19 vaccine, developed by BioNTech-Pfizer. This vaccine marks another important milestone in the fight against the disease. It is the third adaptation of this vaccine to respond to new COVID-19 variants. The vaccine is authorised for adults, children and infants above 6 months. In line with previous recommendations by EMA […]
Read More
Commission acts to accelerate phasing out of animal testing
The Commission is responding to the European Citizens’ Initiative (ECI) ‘Save Cruelty-free Cosmetics – Commit to a Europe without Animal Testing’. The response provides a comprehensive overview of the EU’s legislative and policy framework relevant to the use of animals for testing purposes. It also proposes additional actions to further reduce animal testing. The Commission welcomes […]
Read More
22 de julio: Día Mundial del Cerebro
El 22 de julio se celebra el día mundial del cerebro. La salud mental forma parte integrante de la salud. Es una prioridad para la Comisión, que en los últimos veinticinco años ha apoyado acciones y proyectos que mejoran la salud mental de las personas en la UE y fuera de ella. No te pierdas esta […]
Read More
EU steps up action to prevent shortages of antibiotics for next winter
The European Commission, the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) are today issuing recommendations for actions to avoid shortages of key antibiotics used to treat respiratory infections for European patients in the next winter season. These recommendations, which have been developed through the Executive Steering Group on Shortages and Safety […]
Read More
The Commission and the European Investment Bank announce the creation of HERA Invest
The Commission and the European Investment Bank announce the creation of HERA Invest, a €100 million top-up to the InvestEU programme, to support research and development (R&D) in the most pressing cross-border health threats, financed by the EU4Health programme. Currently, European companies find it difficult to access sufficient public and private funding for the development and scaling up of cutting-edge solutions in health […]
Read More
Eurobarometer: Europeans show more optimism regarding economy
The latest Standard Eurobarometer survey conducted in June 2023 and published yesterday shows that EU citizens continue to back overwhelmingly the energy transition and to expect massive investment in renewables. They continue to widely approve measures taken by the EU to support Ukraine and the Ukrainian people. They also support stronger EU defence cooperation and increased […]
Read More